MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

Cancer Cell

Volumn 29, Issue 1, 2016, Pages 49-60

  Hu, Jing ^a   Sun, Tao ^a   Wang, Hui ^a   Chen, Zhengxin ^c   Wang, Shuai ^c   Yuan, Lifeng ^a   Liu, Tingyu ^a   Li, Hai Ri ^d   Wang, Pingping ^d   Feng, Yukuan ^d,e   Wang, Qinhong ^a   McLendon, Roger E ^b   Friedman, Allan H ^b   Keir, Stephen T ^b   Bigner, Darell D ^b   Rathmell, Jeff ^a   Fu, Xiang dong ^d   Li, Qi Jing ^a   Wang, Huibo ^c   Wang, Xiao Fan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; DROSHA PROTEIN; GLUCOSE TRANSPORTER 1; GLUCURONIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KDM1B PROTEIN; MICRORNA; MICRORNA 129; MICRORNA 134; MICRORNA 155; MICRORNA 215; N ACETYLGALACTOSAMINE; PROTEIN P53; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG; KDM1B PROTEIN, MOUSE; MIRN215 MICRORNA, HUMAN; MIRN215 MICRORNA, MOUSE; N DEMETHYLASE;

ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; HEK293 CELL LINE; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN TUMOR; CELL HYPOXIA; GENE EXPRESSION REGULATION; GENETICS; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR RECURRENCE;

ANIMALS; BRAIN NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICE, NUDE; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; OXIDOREDUCTASES, N-DEMETHYLATING; TUMOR MICROENVIRONMENT;

EID: 84955573535     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2015.12.005     Document Type: Article

References (47)

1. Agrawal R., Pandey P., Jha P., Dwivedi V., Sarkar C., Kulshreshtha R. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing. BMC Genomics 2014, 15:686.
2. Babar I.A., Czochor J., Steinmetz A., Weidhaas J.B., Glazer P.M., Slack F.J. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol. Ther. 2011, 12:908-914.
3. Bandara V., Michael M.Z., Gleadle J.M. Hypoxia represses microRNA biogenesis proteins in breast cancer cells. BMC Cancer 2014, 14:533.
4. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
5. Bhat K.P., Balasubramaniyan V., Vaillant B., Ezhilarasan R., Hummelink K., Hollingsworth F., Wani K., Heathcock L., James J.D., Goodman L.D., et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 2013, 24:331-346.
6. Bhattacharyya S., Tobacman J.K. Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia. PLoS One 2012, 7:e33250.
7. Bruning U., Cerone L., Neufeld Z., Fitzpatrick S.F., Cheong A., Scholz C.C., Simpson D.A., Leonard M.O., Tambuwala M.M., Cummins E.P., Taylor C.T. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol. Cell. Biol. 2011, 31:4087-4096.
8. Chen R.H., Nishimura M.C., Bumbaca S.M., Kharbanda S., Forrest W.F., Kasman I.M., Greve J.M., Soriano R.H., Gilmour L.L., Rivers C.S., et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010, 17:362-375.
9. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., Parada L.F. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
10. Ciccone D.N., Su H., Hevi S., Gay F., Lei H., Bajko J., Xu G.L., Li E., Chen T.P. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 2009, 461:415-418.
11. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
12. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 2010, 39:373-384.
13. Deng Y.J., Huang Z.X., Xu Y.J., Jin J., Zhuo W., Zhang C., Zhang X.T., Shen M.H., Yan X.Y., Wang L.J., et al. MiR-215 modulates gastric cancer cell proliferation by targeting RB1. Cancer Lett. 2014, 342:27-35.
14. Ebert M.S., Neilson J.R., Sharp P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007, 4:721-726.
15. Fang R., Barbera A.J., Xu Y.F., Rutenberg M., Leonor T., Bi Q., Lan F., Mei P.C., Yuan G.C., Lian C., et al. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol. Cell 2010, 39:222-233.
16. Ha M., Kim V.N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 2014, 15:509-524.
17. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
18. Hirose J., Kawashima H., Yoshie O., Tashiro K., Miyasaka M. Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 2001, 276:5228-5234.
19. Huang X., Ding L., Bennewith K.L., Tong R.T., Welford S.M., Ang K.K., Story M., Le Q.T., Giaccia A.J. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 2009, 35:856-867.
20. Jiang J.M., Lee E.J., Gusev Y., Schmittgen T.D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 2005, 33:5394-5403.
21. Jones M.F., Hara T., Francis P., Li X.L., Bilke S., Zhu Y., Pineda M., Subramanian M., Bodmer W.F., Lal A. The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation. Proc. Natl. Acad. Sci. USA 2015, 112:E1550-E1558.
22. Kaur B., Khwaja F.W., Severson E.A., Matheny S.L., Brat D.J., Van Meir E.G. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol. 2005, 7:134-153.
23. Koumenis C., Naczki C., Koritzinsky M., Rastani S., Diehl A., Sonenberg N., Koromilas A., Wouters B.G. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell. Biol. 2002, 22:7405-7416.
24. Kulshreshtha R., Davuluri R.V., Calin G.A., Ivan M. A microRNA component of the hypoxic response. Cell Death Differ. 2008, 15:667-671.
25. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R.E., et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
26. Ling N., Gu J., Lei Z., Li M., Zhao J., Zhang H.T., Li X. microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma. Oncol. Rep. 2013, 30:2111-2118.
27. Liu F.B., You X.N., Chi X.M., Wang T., Ye L.H., Niu J.Q., Zhang X.D. Hepatitis B virus X protein mutant HBx Delta 127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT. Biochem. Biophys. Res. Commun. 2014, 444:128-134.
28. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40:294-309.
29. Mathew L.K., Skuli N., Mucaj V., Lee S.S., Zinn P.O., Sathyan P., Imtiyaz H.Z., Zhang Z.F., Davuluri R.V., Rao S., et al. miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proc. Natl. Acad. Sci. USA 2014, 111:291-296.
30. Mori M., Triboulet R., Mohseni M., Schlegelmilch K., Shrestha K., Camargo F.D., Gregory R.I. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 2014, 156:893-906.
31. Nallamshetty S., Chan S.Y., Loscalzo J. Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic. Bio. Med. 2013, 64:20-30.
32. Ostrom Q.T., Gittleman H., Liao P., Rouse C., Chen Y., Dowling J., Wolinsky Y., Kruchko C., Barnholtz-Sloan J. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014, 16(Suppl 4):iv1-iv63.
33. Rupaimoole R., Wu S.Y., Pradeep S., Ivan C., Pecot C.V., Gharpure K.M., Nagaraja A.S., Armaiz-Pena G.N., McGuire M., Zand B., et al. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat. Commun. 2014, 5:5202.
34. Senanayake U., Das S., Vesely P., Alzoughbi W., Frohlich L.F., Chowdhury P., Leuschner I., Hoefler G., Guertl B. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis 2012, 33:1014-1021.
35. Shen J., Xia W., Khotskaya Y.B., Huo L., Nakanishi K., Lim S.O., Du Y., Wang Y., Chang W.C., Chen C.H., et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 2013, 497:383-387.
36. Soeda A., Park M., Lee D., Mintz A., Androutsellis-Theotokis A., McKay R.D., Engh J., Iwama T., Kunisada T., Kassam A.B., et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1 alpha. Oncogene 2009, 28:3949-3959.
37. Son M.J., Woolard K., Nam D.H., Lee J., Fine H.A. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009, 4:440-452.
38. Sturm D., Bender S., Jones D.T., Lichter P., Grill J., Becher O., Hawkins C., Majewski J., Jones C., Costello J.F., et al. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat. Rev. Cancer 2014, 14:92-107.
39. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
40. Takada W., Fukushima M., Pothacharoen P., Kongtawelert P., Sugahara K. A sulfated glycosaminoglycan array for molecular interactions between glycosaminoglycans and growth factors or anti-glycosaminoglycan antibodies. Anal. Biochem. 2013, 435:123-130.
41. Tong Y.Q., Liu B., Zheng H.Y., Gu J., Liu H., Li F., Tan B.H., Hartman M., Song C., Li Y. MiR-215, an activator of the CTNNBIP1/beta-catenin pathway, is a marker of poor prognosis in human glioma. Oncotarget. 2015, 6:25024-25033.
42. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., Newman J., Bronson R.T., Crowley D., Stone J.R., et al. Targeted deletion reveals essential and overlapping functions of the miR-17 similar to 92 family of miRNA clusters. Cell 2008, 132:875-886.
43. Wang G., Zhao Y., Zheng Y. MiR-122/Wnt/beta-catenin regulatory circuitry sustains glioma progression. Tumour Biol. 2014, 35:8565-8572.
44. Wang H., Sun T., Hu J., Zhang R., Rao Y.H., Wang S., Chen R., McLendon R.E., Friedman A.H., Keir S.T., et al. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. J. Clin. Invest. 2014, 124:4489-4502.
45. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11:228-234.
46. Yan Z., Wang J., Wang C., Jiao Y., Qi W., Che S. miR-96/HBP1/Wnt/beta-catenin regulatory circuitry promotes glioma growth. FEBS Lett. 2014, 588:3038-3046.
47. Yang W., Wei J., Guo T., Shen Y., Liu F. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance. Exp. Cell Res. 2014, 326:22-35.